AstraZeneca COVID-19 Vaccine Information

COVID-19 Vaccine AstraZeneca has provisional consent for the indication below:

Active immunisation to prevent COVID-19 caused by SARS-CoV-2 in individuals 18 years of age and older.  

The use of this vaccine should be in accordance with official recommendations. 

This medicine has been given a provisional consent under Section 23 of the Act.  This means that further evidence on this medicine is awaited or that there are specific conditions of use.  Refer to the consent notice published in the New Zealand Gazette for the specific conditions.

COVID-19 Vaccine AstraZeneca is a prescription only medicine. COVID-19 Vaccine AstraZeneca has risks and benefits. Ask your doctor if COVID-19 Vaccine AstraZeneca is right for you. Use strictly as directed. If symptoms continue or you have side effects, see your doctor, pharmacist or healthcare professional. For product details check the Consumer Medicine Information at www.medsafe.govt.nz.

Please refer to your healthcare professional for further information, or you can contact the AstraZeneca Medical Information team here.

Consumer Medicine Information

 

AstraZeneca Reporting

Report an Adverse Event
Request Medical Information

© AstraZeneca. All rights reserved.

This website is intended for people in New Zealand seeking information on COVID-19 Vaccine AstraZeneca. 

Approval ID: NZ-1335         Date of approval: August 2021

TAPS NA 13162

exit ramp cf

azcovid-cf-text

You are now leaving azcovid-19.com.

This link will take you to a site maintained by a third party who is solely responsible for its contents.

AstraZeneca provides this link as a service to website visitors. AstraZeneca is not responsible for the privacy policy of any third-party websites. We encourage you to read the privacy policy of every website you visit.

Click ‘cancel’ to return to AstraZeneca’s site or ‘continue’ to proceed.
az-cancle-cta
Cancel
az-submit-cta
Continue